Its unique action of simultaneously stimulating both GIP and GLP-1 receptors enhances glucose-dependent insulin secretion, reduces glucagon secretion, and slows gastric emptying, ultimately resulting in significant weight loss and better glycemic control
If youre planning to conceive, your prescriber will usually advise stopping the medication ahead of trying
Semaglutide Overview Semaglutide is a GLP-1 receptor agonist initially used for managing type 2 diabetes but has recently been approved for weight management under the brand name Wegovy
SS-31, also known as elamipretide, is a synthetic tetrapeptide that selectively targets the inner mitochondrial membrane by binding to cardiolipin, a phospholipid essential for mitochondrial structure and energy production
While Semaglutide makes weight loss easier, pairing it with healthy eating and activity maximizes results and helps you maintain your weight